Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6113681 | Critical Reviews in Oncology/Hematology | 2013 | 15 Pages |
Abstract
We discuss the general benefits of estrogen therapy to quality of life of men on ADT, the potential risks of this treatment, and possible treatment regimes for estrogen therapy in males. Unless contraindicated, we propose that PCa patients on ADT would benefit from supplemental parenteral estrogen.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Erik Wibowo, Richard J. Wassersug,